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Association of juvenile idiopathic arthritis
with PTPN22 rs2476601 is specific to
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Abstract
Background: Juvenile idiopathic arthritis (JIA) is an autoimmune disease characterized by persistent chronic
arthritis. Disease risk is believed to be influenced by both genetic and environmental factors. It is well established
that the PTPN22 single nucleotide polymorphism (SNP) rs2476601 is associated with JIA susceptibility. It was
recently reported in an Australian study that this association is restricted to females and is not observed in males.
A significant source of inconsistency amongst the literature on autoimmune disease susceptibility genes stems
from an inability to replicate genetic findings across different racial or ethnic groups. We therefore attempted to
generate further evidence of the female-specific association of rs2476601 in a homogeneous Greek population.
Findings: We genotyped rs2476601 in 128 Caucasian JIA patients (70.3 % female) and 221 healthy controls
(28.1 % female) from Northern Greece. Overall, PTPN22 was associated with increased risk of JIA in this Greek
sample (OR = 2.3, 95 % CI 1.1 – 5.1, p = 0.038). Sex-stratified analyses showed that, once again, the risk association
was restricted to females (Female: OR = 19.9, 95 % CI 1.2 – 342, p = 0.0016; Male: OR = 1.1, 95 % CI 0.3 – 3.1,
p = 0.94) supporting the prior findings.
Conclusions: Our data demonstrates that this sex-specific pattern of association is broadly applicable to different
populations, and provides further impetus to undertake mechanistic studies to understand the impact of sex on
PTPN22 in JIA.
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Introduction
Autoimmunity is believed to result from a combination
of genetic factors and environmental triggers and one
feature that is shared among many autoimmune disor-
ders, including juvenile idiopathic arthritis (JIA), is the
increased proportion of females that develop the dis-
order. The reason for the observed sex bias remains
elusive, and relatively few studies have comprehensively
investigated this phenomenon from a mechanistic per-
spective, especially in JIA.
JIA is the most common chronic arthritis of child-
hood [1] and is associated with significant morbidity.
JIA is an umbrella term that encompasses a heterogeneous
group of disorders (subtypes) all characterized by pro-
longed synovial inflammation that may cause destructive
damage to joint structures [2]. The subtypes oligoarthritis
(both persistent and extended) and rheumatoid factor
(RF)–negative polyarthritis are considered the most
homogeneous subtypes, with shared phenotypic features,
while systemic JIA has a more distinct phenotype resem-
bling an autoinflammatory syndrome [3]. Interestingly,
not all JIA subtypes are more common in females, but the
oligoarticular and polyarticular subtypes, which constitute
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around 70 % of all cases, occur 2-3 times more frequently
in girls [1].
Accumulated evidence indicates that ethnic hetero-
geneity may complicate genetic association studies in
rheumatic diseases [4–7]. There is substantial ethnic
variability in allele frequencies of common single nu-
cleotide polymorphisms (SNPs) that have been catalo-
gued since the completion of the human genome
sequence. Polymorphisms in various genes associated
with rheumatic diseases have been reported to vary
substantially by allele frequency in different ethnic
groups [8, 9].
A non-synonymous SNP, rs2476601 (also referred to
as C1858T or R620W), located in the gene encoding
protein tyrosine phosphatase nonreceptor 22 (PTPN22)
has been repeatedly associated with a wide range of
autoimmune diseases, including JIA [10]. While the
data are inconsistent, multiple recent studies have sug-
gested that this SNP may be associated with disease in
a sex-specific manner. For example, in type 1 diabetes,
rs2476601 appears only related to disease risk in fe-
males [11–13]. The same SNP was found to be associ-
ated only in males with psoriatic arthritis (PsA) [14]
and rheumatoid arthritis (RA) [15].
In relation to JIA, it was recently reported that PTPN22
rs2476601 is associated with JIA only in females in an
Australian case-control sample. The finding was replicated
in a second case-control sample from the US and Norway
[16]. This present study aimed to investigate whether the
female-specific association can also be observed in further
ethnic groups by performing sex stratified association ana-
lysis in a Greek JIA case-control sample.
Materials and methods
Patient population and study design
In this case-control association study, one hundred and
twenty eight JIA patients (70.3 % female), followed in
the Rheumatology Units of the 4th Medical Department
of Internal Medicine and the 1st Medical Department of
Pediatrics of Aristotelian University of Thessaloniki
Hospital (Northern Greece) were available for analysis.
Only patients who fulfilled the 2001 revised Inter-
national League of Associations for Rheumatology
(ILAR) criteria for JIA and gave their informed consent
were eligible for the study. Cases were of mixed ILAR
subtype, as detailed in [6]. Two hundred and eleven
controls (28.1 % female) were also available. Controls
consisted of healthy subjects without autoimmune or
chronic inflammatory disease, or an acute or chronic
infectious disease; and were recruited from the Transfu-
sion Medicine Department of Hippokration Hospital of
Thessaloniki (Greece). Cases and controls, including
criteria for study inclusion, are described in further de-
tail in [6]. All patients were of self- or parent-reported
Greek origin. The study was approved by the local
Ethics Committee for medical research (General Assem-
bly of the Medical School of the Aristotle University of
Thessaloniki and Hippokration Hospital, G.A. 06/07-11-
2007) and was carried out in compliance with the declar-
ation of Helsinki.
Genotyping
Genomic DNA was isolated from peripheral blood
leukocytes by using the commercial kit PUREGENE
(Gentra Systems, Minneapolis, MN) according to
the manufacturer’s instructions and genotyping was
performed for the PTPN22 rs2476601 (XcmI)
polymorphism by restriction fragment length poly-
morphism (RFLP) analysis as described previously
[4].
Statistical analysis
Initial statistical analyses were performed using
GraphPad Prism statistical program (GraphPad Soft-
ware, San Diego, CA). All cases and controls used in
the analysis were unrelated. The genetic variant under
investigation was evaluated for deviation from Hardy–
Weinberg equilibrium (HWE) by comparing observed
and expected genotype frequencies by means of chi-
squared (x2) test both in case and control groups.
The HWE test was performed in combination with an
analysis for ascertainment bias for dominant/recessive
models (due to biological or technical causes) by using
the program "Calculate" (Copyright TRG, SR, INMD,
2008). Further statistical analyses were undertaken
using Stata v14 (StataCorp, College Station, TX, USA).
Logistic regression was used to generate ORs and
95 % CIs for the association of rs2476601 with JIA.
For analyses where logistic regression could not be
performed because of the absence of the minor allele
in any one group, we used the Gart method [17] with
a continuity correction delta = 0.5 (also known as the
Woolf method) to estimate ORs and 95 % CIs, and
Fisher’s exact test to determine the P-value. We also
performed a ‘pooled control’ analysis (female cases
compared to all controls and male cases combined),
following past work on PTPN22 and JIA in other pop-
ulations [16]. A P value less than 0.05 was considered
significant.
Results and discussion
Allele frequencies of the PTPN22 rs2476601 C/T SNP in
males and females are shown in Table 1. No deviation
from HWE was observed in either cases or controls.
Overall (both sexes together), we observed a significant
association of rs2476601 with JIA in this Greek popula-
tion (OR = 2.3, 95 % CI 1.1 – 5.1, p = 0.038) in a direc-
tion consistent with previous findings. When stratified
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by sex, we observed association of rs2476601 with in-
creased risk of JIA in females (OR = 19.9, 95 % CI 1.2 –
342, p = 0.0016). The wide confidence interval reflects
the small sample size, and the fact that no minor al-
leles were observed in female controls. The pooled-
control analysis, which hypothesizes that male JIA risk
is not affected by rs2476601 and therefore male cases
are essentially controls, further supported an associ-
ation of rs2476601 with female JIA (OR = 2.5, 95 % CI
1.1 – 5.6, p = 0.025). In males, no association between
rs2476601 and JIA was observed (OR = 1.1, 95 % CI 0.3
– 3.1, p = 0.94). Exclusion of systemic JIA cases did not
materially alter the findings. This sex-specific pattern
of association, including the direction of effect, is con-
sistent with the prior study conducted in Australian,
US and Norwegian samples [16]. Given that the sex
bias differs by JIA subtype, ideally we would have liked
to test for these associations in individual subtypes;
however, small sample size (for details see [6]) pre-
vented us from performing these analyses with any
statistical certainty.
Over the last decade, several studies have investigated
candidate genes to discover or confirm associations with
JIA phenotypes (e.g. [18]). Importantly, associations of
gene variants with JIA have not always replicated when
tested in different populations [19]. This is the first study
examining the association of PTPN22 rs2476601 specif-
ically with JIA in female patients in a population from
Greece.
PTPN22 contributes to the modulation of negative T
cell selection in the thymus and downregulation of
autoreactive T cells in the periphery [20]. It has been
demonstrated that PTPN22 increases phosphatase ac-
tivity when the minor ‘T’ allele of rs2476601 is present
[21]. As a consequence, this gain of function associated
with the ‘T’ allele may suppresses T cell signaling more
efficiently and lead to a failure in apoptosis of autoreac-
tive T cells and to insufficient activity of regulatory T
cells [22]. Taking into consideration that females have
higher numbers of CD4 lymphocytes than males and
higher levels of Th1 cytokines [23], the observed role of
the PTPN22 polymorphism may be mainly relevant to
females [13].
PTPN22 rs2476601 shows a wide variation in “T” al-
lele frequencies among different ethnic populations,
with a North–South gradient in Europe ranging be-
tween 15.5 % (north) and 2.1 % (south) [8]. Lee et al.
[24] reported that this allele frequency ranged between
15.8 and 8.7 % for JIA patients and 11.6 and 7.8 % for
controls. Accordingly, the observed presence of the
rs2476601 minor allele in Greece was lower than that
in North or Central European populations but similar
to that in a Turkish population, which is geographically
closer to Greece [5]. However, despite this, the SNP has
shown an association with JIA, specifically in females,
in this Greek case-control sample [6].
In conclusion, our results provide additional evidence
for a female-specific association between the rs2476601
PTPN22 SNP and the risk of JIA by independent
replication in a Greek population, demonstrating the
broader applicability of this finding across various
ethnic groups. This locus is of particular interest in this
context given that the genetic variant under investiga-
tion occurs at different frequency in the Greek popula-
tion compared to other European populations. The
importance of comparative studies in populations of
different ethnic and/or racial origins is high in any
attempt to conclusively define the genetic architecture
of JIA and the magnitude of the effects of specific risk
alleles in different populations.
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